Cite
HARVARD Citation
Lee, B. et al. (2021). Cost–benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin. Clinical microbiology and infection. pp. 1346.e1-1346.e7. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, B. et al. (2021). Cost–benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin. Clinical microbiology and infection. pp. 1346.e1-1346.e7. [Online].